print logo

Contact Our Offices

Clinical Trials

Reset Text Size: A A A

Diabetic Retinopathy

Completed Studies

Cystoid Macular Edema after Cataract Surgery (Allergan)

Phase 2 Study of the Dexamethasone Intravitreal Implant (Ozurdex) for combined Pseudophakic Cystoid Edema and Diabetic Macular Edema after cataract surgery.

DA VINCI (Regeneron)

Phase 2 study of the safety, tolerability and biological effect of repeated aflibercept (Eylea) in diabetic macular edema.

DEGAS (Pfizer)

Phase 2 study of the efficacy and safety of PF-04523655 versus laser in diabetic macular edema.

PACIFIC (Allegro)

A 6 month, phase 2, randomized, double-masked, placebo-controlled multicenter clinical trial designed to evaluate the safety and efficacy of Luminate in inducing PVD in subjects with non-proliferative diabetic retinopathy.

PANORAMA (Regeneron)

A 2 year, Phase 3, multicenter, randomized study of the efficacy and safety of intravitreal aflibercept (Eylea) injection in patients with moderately severe to severe nonproliferative diabetic retinopathy.

RIDE (Genentech)

Phase 3 study of the efficacy and safety of Ranibizumab (Lucentis) in diabetic macular edema.

VISTA (Regeneron)

A 3 year Phase 3 study of the efficacy, safety and tolerability of aflibercept (Eylea) in patients with diabetic macular edema.